Rania M Labib
Overview
Explore the profile of Rania M Labib including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
58
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alyateem G, Wade H, Bickert A, Lipsey C, Mondal P, Smith M, et al.
Cancer Gene Ther
. 2023 Apr;
30(8):1043-1050.
PMID: 37029320
Despite the development of new classes of targeted anti-cancer drugs, the curative treatment of metastatic solid tumors remains out of reach owing to the development of resistance to current chemotherapeutics....
2.
Catchpoole D, Carpentieri D, Vercauteren S, Wadhwa L, Schleif W, Zhou L, et al.
Biopreserv Biobank
. 2020 Jul;
18(4):258-265.
PMID: 32706974
No abstract available.
3.
Abdelhafiz A, Sultan E, Ziady H, Ahmed E, Khairy W, Sayed D, et al.
BMC Med Ethics
. 2019 Aug;
20(1):57.
PMID: 31399100
Background: Biobanking is a relatively new concept in Egypt. Building a good relationship with different stakeholders is essential for the social sustainability of biobanks. To establish this relationship, it is...
4.
Labib R, Hassanain O, Alaa M, Ahmed S, Abou El-Naga S
Front Oncol
. 2018 Jan;
7:324.
PMID: 29376026
Background: Biobanks have become a powerful tool that fosters biomedical research. The success of biobanks depends upon people's perception and willingness to donate their samples for research. This is the...
5.
Labib R, Abdelrahim M, Elnadi E, Hesham R, Yassin D
PLoS One
. 2016 Jul;
11(7):e0158890.
PMID: 27388155
Background: Rhabdomyosarcoma (RMS) is a small round blue cell malignant tumor, representing 7% of childhood malignancies, and over 50% of all soft tissue sarcomas. Cyclophosphamide (CPA) is a prodrug and...
6.
Alfaar A, Nour R, Bakry M, Kamal M, Hassanain O, Labib R, et al.
Int Ophthalmol
. 2016 Apr;
37(1):111-118.
PMID: 27113056
Research on childhood diseases represents a great global challenge. This challenge is maximized in both childhood cancer disciplines and developing world. In this paper, we aim at describing our institution...
7.
Labib R, Mostafa M, Alfaar A, Yehia D, Alaa M, Elzayat M, et al.
Biopreserv Biobank
. 2015 Dec;
14(1):9-16.
PMID: 26691960
Background: Conducting high throughput -omics research requires high quality, data-rich biospecimens to unravel factors underlying childhood cancers; this is an extra burden in a limited resources country. For this purpose,...
8.
El Nadi E, Moussa E, Zekri W, Taha H, Yones A, Zaghloul M, et al.
Sarcoma
. 2015 Oct;
2015:721253.
PMID: 26491397
[This corrects the article DOI: 10.1155/2013/439213.].
9.
El Nadi E, Moussa E, Zekri W, Taha H, Yones A, Zaghloul M, et al.
Sarcoma
. 2013 Aug;
2013:439213.
PMID: 23983569
Background. Rhabdomyosarcoma (RMS) is the most common soft-tissue sarcoma in children. Fifty percent of RMS cases occur in the first 10 years of life and less commonly in infants younger...
10.
Outcome of pediatric parameningeal rhabdomyosarcoma. The Children Cancer Hospital, Egypt, experience
Abdel Rahman H, Sedky M, Mohsen I, Taha H, Loaye I, Zaghloul M, et al.
J Egypt Natl Canc Inst
. 2013 May;
25(2):79-86.
PMID: 23719406
Background: PM RMS represents a diagnostic and therapeutic problem as it is less visible than other superficial head and neck sites, and has tendency to local and intracranial extension. Objectives:...